Board summary
Key figures
47,291
Registered population
62.2% aged 18–64
12.9%
Aged 65+
ICB 20.0% · England 17.9%
23.2%
Ethnic minority (non-White)
20.7% Asian · England 9.6%
58.1%
In IMD quintile 1
ICB 30.6% · England 21.0%
~23,392
Core20 residents (est.)
Resident basis; registered basis ~27,462 · see page 3
6,454
Hypertension register
+6.92% in 3 yrs · England +5.60%
595
SMI register
23.8% of Blackburn with Darwen (LAD)'s
703
COPD register
Reviews -5.88% in 3 yrs
Forecast to 2030
7,360
Hypertension patients, 2030
+906 on today
82.7%
QRISK ≥20% on statins, 2030
+4.56pp over 3 yrs
2.8%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
COPD reviews and register fell over three years.
COPD annual reviews fell 5.9% (England +2.8%) and register prevalence fell 4.5% (England +2.6%) over 2023 to 2025, which may reflect review backlogs.
Preventive screening and pre-school boosters trail benchmarks.
Cervical screening in ages 25-49 is 54.7% (England 66.8%), breast screening in ages 53-70 is 55.8% (England 69.9%), and age-5 4-in-1 coverage is 81.8%.
Lipid therapy in high-risk cohorts exceeds England.
Lipid-lowering therapy for QRISK >= 20% reaches 72.7% (England 63.6%), and statin treatment in diabetes with CVD reaches 89.8% (England 84.4%).
Population, age and ethnicity
With 24.9% aged 0-17, the PCN has a younger profile than England
Across 47,291 registered patients, 24.9% are aged 0-17 (borough 24.0%, ICB 19.6%, England 19.6%) and 12.9% are aged 65+ (borough 13.5%, ICB 20.0%, England 17.9%). Census usual residents show 20.7% Asian or Asian British (borough 35.7%, ICB 9.4%, England 9.6%). Projected list growth to 2030 is 0.1% (borough 0.6%, ICB 1.7%, England 2.3%; unverified methodology). This younger profile may concentrate paediatric demand, which local audits can assess, while Census Asian usual residents span from 3.8% at Hollins Grove Surgery to 78.6% at Olive Medical Centre.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackburn with Darwen (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackburn with Darwen LA) | 1,724 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 81.1% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 53.3% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackburn with Darwen LA) | 951 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackburn with Darwen LA) | 16.5 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation reaches 58.1% across the PCN and varies sharply across practices
Across the PCN, 58.1% of registered patients live in Core20 areas, compared with 59.6% in the borough, 30.6% in the ICB, and 21.0% in England. Core20 concentration spans an 85.8 pp range across practices, from 2.6% at Brownhill Surgery to 88.5% at Hollins Grove Surgery. Patient volume is concentrated at Shifa Surgery (8,140 estimated Core20 patients, 71.4% share) and Blakewater Healthcare (6,009 patients, 56.3% share). The PCN should combine community-based outreach in high-concentration practices with enhanced clinical recall capacity in high-volume practices.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
595
SMI register
1.23% recorded prevalence
279
Learning disability register
0.58% recorded prevalence
25
Care homes, 770 beds
In the PCN catchment
9.9%
Provide unpaid care
Blackburn with Darwen (LAD), Census 2021
The PCN registers 595 patients with severe mental illness (1.2%, borough 1.3%, ICB 1.2%, England 1.0%) and 279 with learning disabilities (0.6%, matching borough, ICB, and England). The catchment includes 25 care homes with 770 beds, though resident registration is unconfirmed.
Severe mental illness: physical health checks
Annual blood pressure checks for patients on the SMI register reached 78.5% (England 83.4%, ICB 79.8%), while BMI checks reached 78.7% (England 82.1%, ICB 76.8%). Both indicators trail national benchmarks.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,454
Hypertension register
+6.92%
Register growth, 3 yrs
Blackburn with Darwen (LAD) +4.97% · England +5.60%
+1.17pp
BP control, under 80
≤140/90 · +2.81pp aged 80+
+906
More patients by 2030
Forecast 7,360 (15.22%)
Hypertension case-finding and control
Recorded hypertension prevalence is 13.3% (6,454 patients), below Blackburn with Darwen (15.0%), the ICB (17.2%), and England (15.2%). Prevalence rose +6.9% over three years (England +5.6%). Among patients aged under 80 with hypertension, 67.5% had blood pressure <= 140/90 mmHg, above Blackburn with Darwen (66.2%) and the ICB (67.1%) but below England (67.8%), while three-year control growth (+1.8%) lagged England (+3.2%). Lagging blood pressure control growth compared to England could reflect review backlogs, which local audit can evaluate.
Lipids and statins
Lipid-lowering therapy for patients with QRISK >= 20% is 72.7%, above Blackburn with Darwen (66.0%), the ICB (61.4%), and England (63.6%). For patients with diabetes and history of cardiovascular disease, statin treatment is 89.8%, exceeding England (84.4%), Blackburn with Darwen (87.4%), and the ICB (84.1%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 87,304 | £1.60 | £1.64 | £1.86 | £139,686 |
| Cardiovascular (all), 2025 | 110,934 | £3.13 | £3.38 | £3.33 | £347,223 |
For lipid-regulating drugs in 2026, the PCN prescribed 87,304 items at £1.60 per item (spend £139,686), below Blackburn with Darwen (£1.83), the ICB (£1.64), and England (£1.86), spending £22,699 less than at England's unit cost across those items.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+0.16%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−1.72%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 1.4% (England 1.9%) and fell 4.5% over three years (England +2.6%). While COPD reviews reached 80.9% (England 76.4%), reviews fell 5.9% over three years (England +2.8%). Asthma prevalence is 6.9% (England 6.6%), with annual reviews at 68.7% (England 65.7%), leaving a modelled 971 patients without a recorded review. Asthma prescribing in ages 5-19 was 1,182 items per 1,000 (England 1,488). Slower review growth could reflect review backlog, which local audit can test.
Cancer register and children's immunisation
Cancer register prevalence is 2.4% (England 3.8%, ICB 4.3%). For childhood immunisations, 12-month 6-in-1 coverage reached 86.7% (England 91.0%), below the 95.0% target by 8.3 pp. At age 5, MMR coverage drops 6.7 pp from dose 1 (93.2%) to dose 2 (86.5%), and the 4-in-1 pre-school booster reaches 81.8%, below the 95.0% target by 13.2 pp.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of staged cancers (4,642 of 8,863) were diagnosed at stage 1 or 2, trailing England (55.3%) and 22.6 pp below the 75.0% national ambition. Known-stage share was 74.6% (8,863 of 11,883). Reaching 75.0% across the ICB would require about 2,010 additional early-stage diagnoses annually. Staging reflects ICB pathways, not PCN delivery. For PCN screening, cervical uptake is 54.7% (England 66.8%), including 42.2% at Olive Medical Centre and 46.1% at Primrose Bank Medical Centre, while breast screening is 55.8% (England 69.9%). Screening below national benchmarks may indicate delayed detection opportunities, which practice audits can evaluate.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In provisional July 2026 data, East Lancashire Hospitals NHS Trust achieved 73.2% for the 62-day cancer referral to treatment standard, below the 85.0% standard and trailing Northern Care Alliance NHS Foundation Trust (78.6%), Lancashire Teaching Hospitals NHS Foundation Trust (75.0%), and the ICB (73.6%), but above England (71.2%). The trust met the 28-day faster diagnosis standard at 81.5% (standard 75.0%; England 79.3%) and 31-day treatment at 98.1% (standard 96.0%; England 92.5%). Diagnostic 6-week waits were 0.4% for MRI and 0.1% for CT (England 21.4% and 9.9%). Provider figures describe hospital pathways rather than PCN performance.
| Pathways within standard (%) | East Lancashire | Lancashire | Northern Care Alliance | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 81.50 | 82.90 | 75.20 | 78.39 | 79.32 |
| 31-day treatment (96%) | 98.11 | 89.43 | 94.54 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 73.16 | 75.04 | 78.65 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Lancashire | Lancashire | Northern Care Alliance | England |
|---|---|---|---|---|
| MRI | 0.43 | 2.41 | 5.09 | 21.40 |
| CT | 0.15 | 14.97 | 4.10 | 9.92 |
| Echocardiography | 0.00 | 13.85 | 31.48 | 28.48 |
| Colonoscopy | 0.95 | 0.00 | 40.04 | 30.83 |
| Gastroscopy | 1.16 | 0.00 | 36.48 | 29.02 |
| All 15 DM01 tests | 3.25 | 26.65 | 15.71 | 23.14 |
| Community services activity | Blackburn With Darwen residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 535 | 193,720 |
| Referrals | 230 | 29,855 |
| Patients with a contact | 305 | 65,335 |
Community services (residents of Blackburn With Darwen), Jun 2026 (provisional). For Blackburn with Darwen residents in June 2026 (provisional), community health service activity recorded 535 contacts. Adults aged 65 and over accounted for 195 of these contacts, representing a 36.4% share. These captured metrics reflect local authority resident intermediate care activity rather than PCN caseloads.
Practice variation and patient experience
Practice phone access varies widely, spanning 52.5 pp between lowest and highest practices
Clinical QOF achievement reached 100.0% at Brownhill Surgery and Shifa Surgery in 2025/26. In contrast, vaccination and immunisation domain achievement spans 84.4 pp across practices, from 15.6% at Olive Medical Centre to 100.0% at Blakewater Healthcare (England 55.2%). This divergence suggests that high clinical domain scores may not reflect uniform delivery across childhood immunisations.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Hollins Grove | 96 | 88.5 | 80.2% | 75.7% | 90.3% |
| Brownhill Surgery | 105 | 2.6 | 60.4% | 70.2% | 75.3% |
| Blakewater | 77 | 56.3 | 53.8% | 70.6% | 69.7% |
| Shifa Surgery | 61 | 71.4 | 50.4% | 71.6% | 65.0% |
| Olive | 87 | 74.4 | 27.7% | 74.0% | 62.9% |
| Primrose Bank | 133 | 61.1 | 39.4% | 63.1% | 54.4% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Twelve of 25 tracked measures trail England over three years, led by COPD
Across 25 tracked measures, 12 trail England's three-year change. The widest lags are in COPD annual reviews, which fell 5.9% (England +2.8%), and COPD prevalence, which fell 4.5% (England +2.6%). Dementia prevalence rose +0.9% (England +6.0%). Conversely, heart failure reviews rose +25.0% (England +8.7%) to 85.0% (England 78.5%), and learning disability prevalence rose +23.7% (England +5.4%). Trailing register trajectories could reflect diagnostic backlogs rather than lower underlying disease burden, which practice audits can evaluate.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
COPD reviews
COPD register
Dementia register
Asthma reviews
Stroke register
Heart failure reviews
Breast screening (53-70)
Diabetes HbA1c control
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackburn with Darwen (LAD) | Asset | PCN | Blackburn with Darwen (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 25 (770 beds) | n/a | Schools (catchment) | 84 | n/a |
| Children's centres | 8 | 13 | Places of worship | 64 | 99 |
| Libraries | 2 | 6 | Primary schools (LA maintained) | 25 | 45 |
| Primary academies | 3 | 6 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Respiratory annual review recall
Asthma reviews reach 68.7% (England 65.7%), leaving a modelled 971 of 3,105 register patients unreviewed, while COPD reviews (80.9%) fell 5.9% over three years (England +2.8%). For discussion: the PCN could run structured asthma and COPD recall using a single template and flexible slots. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Screening and pre-school booster outreach
Cervical screening (ages 25-49) is 54.7% (England 66.8%), breast screening is 55.8% (England 69.9%), and age-5 4-in-1 booster coverage is 81.8% (below the 95.0% target by 13.2 pp). For discussion: practices could trial adapted reminders, telephone follow-up, and flexible clinic slots for screening and boosters. Moderate effort to run.
Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.
Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.
Option 3
SMI physical health check completion
Across 595 SMI register patients, 12-month blood pressure checks reach 78.5% (-4.9 percentage points vs England 83.4%, -1.3 percentage points vs ICB 79.8%, 1.4 percentage points vs LAD 77.1%) and 12-month BMI checks reach 78.7% (-3.4 percentage points vs England 82.1%, 1.9 percentage points vs ICB 76.8%, 3.7 percentage points. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Tailored communication review (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Two-track Core20 outreach and recall (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Severe mental illness check recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension recall and titration audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall outreach (p6) | 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Screening recall outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Telephony and triage workflow review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Respiratory annual review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD patients with a review in the last 12 months | Core20PLUS5 respiratory | PCN |
| Option 2 · Screening and pre-school booster outreach (p12) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) · Breast screening coverage: aged 53 to 70 years old · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN & Practice |
| Option 3 · SMI physical health check completion (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
